Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Revenue | 147.20K | 166.20K | 135.80K | 110.80K | 77.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 147.20K | 166.20K | 135.80K | 110.80K | 77.20K |
| Cost of Revenue | 15.00K | 17.00K | 9.00K | 13.50K | 15.30K |
| Gross Profit | 132.20K | 149.20K | 126.80K | 97.20K | 61.90K |
| SG&A Expenses | 179.50K | 162.10K | 135.10K | 494.20K | 147.40K |
| Depreciation & Amortization | 15.40K | 15.00K | 15.00K | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 209.90K | 194.10K | 159.10K | 507.80K | 162.70K |
| Operating Income | -62.70K | -27.80K | -23.30K | -396.90K | -85.50K |
| Income Before Tax | -2.36M | -464.20K | -934.40K | -1.36M | -25.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.36M | -464.20K | -934.40K | -1.36M | -25.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.36M | -464.20K | -934.40K | -1.37M | -25.50K |
| EBIT | -62.70K | -27.80K | -23.30K | -396.90K | -85.50K |
| EBITDA | -47.10K | -12.70K | -8.20K | -381.80K | -85.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 5.46B | 2.50B | 882.24M | 71.29M | 75.86M |
| Average Diluted Shares Outstanding | 5.46B | 2.50B | 882.24M | 71.29M | 75.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
